OA11993A - Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant. - Google Patents

Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant. Download PDF

Info

Publication number
OA11993A
OA11993A OA1200200019A OA1200200019A OA11993A OA 11993 A OA11993 A OA 11993A OA 1200200019 A OA1200200019 A OA 1200200019A OA 1200200019 A OA1200200019 A OA 1200200019A OA 11993 A OA11993 A OA 11993A
Authority
OA
OAPI
Prior art keywords
suspension
pivalate
surfactant
volume
suspension according
Prior art date
Application number
OA1200200019A
Other languages
English (en)
French (fr)
Inventor
Bernard Doat
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of OA11993A publication Critical patent/OA11993A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Cartons (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Polymerisation Methods In General (AREA)
  • Vehicle Body Suspensions (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA1200200019A 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant. OA11993A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (fr) 1999-07-22 1999-07-22 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant

Publications (1)

Publication Number Publication Date
OA11993A true OA11993A (fr) 2006-04-18

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200019A OA11993A (fr) 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant.

Country Status (25)

Country Link
EP (1) EP1200096B1 (cs)
JP (1) JP2003505421A (cs)
KR (1) KR100718211B1 (cs)
AT (1) ATE269088T1 (cs)
AU (1) AU6296700A (cs)
BG (1) BG106358A (cs)
BR (1) BR0012671A (cs)
CA (1) CA2378390C (cs)
CZ (1) CZ2002144A3 (cs)
DE (1) DE60011620T2 (cs)
DK (1) DK1200096T3 (cs)
DZ (1) DZ3207A1 (cs)
EE (1) EE200200039A (cs)
ES (1) ES2219366T3 (cs)
FR (1) FR2796553B1 (cs)
HK (1) HK1046850B (cs)
HU (1) HUP0202055A3 (cs)
IS (1) IS6228A (cs)
MX (1) MXPA02000834A (cs)
NO (1) NO20020252L (cs)
OA (1) OA11993A (cs)
PL (1) PL354100A1 (cs)
PT (1) PT1200096E (cs)
SK (1) SK762002A3 (cs)
WO (1) WO2001007053A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5317512B2 (ja) * 2008-03-31 2013-10-16 小林製薬株式会社 含嗽用組成物
JP5461785B2 (ja) * 2008-03-31 2014-04-02 小林製薬株式会社 繰り返し感染予防用の医薬組成物
JP2013123450A (ja) * 2011-12-13 2013-06-24 Akihiro Sato 金属錯体イオン液を応用した塵肺の療養方法、および、咽頭・気管・気管支の療養方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
FR2796553B1 (fr) 2001-09-28
HK1046850A1 (en) 2003-01-30
WO2001007053A1 (fr) 2001-02-01
CZ2002144A3 (cs) 2002-06-12
MXPA02000834A (es) 2003-07-14
NO20020252D0 (no) 2002-01-17
AU6296700A (en) 2001-02-13
DZ3207A1 (fr) 2001-02-01
CA2378390A1 (en) 2001-02-01
NO20020252L (no) 2002-01-17
BG106358A (bg) 2002-08-30
IS6228A (is) 2002-01-15
EP1200096A1 (fr) 2002-05-02
KR20020012010A (ko) 2002-02-09
KR100718211B1 (ko) 2007-05-15
DK1200096T3 (da) 2004-09-13
HUP0202055A2 (en) 2002-09-28
DE60011620D1 (de) 2004-07-22
DE60011620T2 (de) 2005-07-21
ES2219366T3 (es) 2004-12-01
HK1046850B (zh) 2004-12-31
ATE269088T1 (de) 2004-07-15
BR0012671A (pt) 2002-04-09
HUP0202055A3 (en) 2009-03-30
EE200200039A (et) 2003-04-15
EP1200096B1 (fr) 2004-06-16
FR2796553A1 (fr) 2001-01-26
SK762002A3 (en) 2002-08-06
PL354100A1 (en) 2003-12-29
CA2378390C (en) 2008-09-23
PT1200096E (pt) 2004-10-29
JP2003505421A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
JP3350061B2 (ja) エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
FI91217B (fi) Farmaseuttisen tai diagnostisen aineen oftalmologinen kantoainekoostumus
CA2802816C (fr) Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
RU2646802C2 (ru) Растворы на основе мелатонина и порошки для их получения
HU199678B (en) Process for producing aerosols containing nitroglicerol
US20040152664A1 (en) Prednisolone compositions
TW200528114A (en) Compositions and methods for treating a posterior segment of an eye
HU209436B (en) Process for producing pharmaceutical solutions containing macrolides
OA11993A (fr) Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant.
IE920516A1 (en) Steroid Formulations
EP3669879B1 (fr) Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoïque comprenant de la diosmine et de la gomme xanthane
FR2618333A1 (fr) Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
EP0867181A1 (en) Nasal melatonin composition
WO2005101982A2 (en) A stable ophthalmic composition
TW201330849A (zh) 用於鼻內施用褪黑素的藥物組合物
JP2003055201A (ja) ビタミンａ類含有可溶化組成物及びビタミンａ類の安定化方法
EP2827840B1 (fr) Solution ophtalmique aqueuse a base de ciclosporine a
KR100509432B1 (ko) Ｓ(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
AP1100A (en) Pharaceutical compositions containing eletriptan hemisulphate.
RU2336074C2 (ru) Композиции и способы лечения заднего сегмента глаза
UA158064U (uk) Спосіб отримання водорозчинного протипаразитарного супрамолекулярного комплексу з нітенпірамом
Kim et al. Development of fast dissolving tablet containing herb extract by freeze-drying technique
HUT77445A (hu) Gyulladásgátló szemcsepp
FR2746014A1 (fr) Composition ophtalmologique du type subissant une transition de phase liquide-gel
MXPA00004846A (es) Formulaciones nasales de citrato de sildenafil.